Saima Zameer

Linagliptin, a DPP-4 inhibitor, ameliorates Aβ (1−42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease

Nazia Siddiqui, Javed Ali, Suhel Parvez et al. · Neuropharmacology · 2021 · 59 citations

Neurodegenerative Diseases, Alzheimer's Disease, Biochemistry +12

Betulinic acid, a natural PDE inhibitor restores hippocampal cAMP/cGMP and BDNF, improve cerebral blood flow and recover memory deficits in permanent BCCAO induced vascular dementia in rats

Madhu Kaundal, Saima Zameer, Abul Kalam Najmi et al. · European Journal of Pharmacology · 2018 · 58 citations

Alzheimer's Disease, Medicine, Dementia +13

Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer’s disease in intracerebroventricular streptozotocin model for brain delivery

Saima Zameer, Javed Ali, Divya Vohora et al. · Journal of drug targeting · 2020 · 44 citations

Engineering of QbD driven and ultrasonically shaped lyotropic liquid crystalline nanoparticles for Apigenin in the management of skin cancer

Ayesha Waheed, Saima Zameer, Niha Sultana et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2022 · 38 citations

Nanoparticles, Nanomedicine, Biofunctional Material +8

Effect of aromatase inhibitors on learning and memory and modulation of hippocampal dickkopf-1 and sclerostin in female mice

Saima Zameer, Divya Vohora · Pharmacological Reports · 2017 · 36 citations

Aromatase Inhibitors, Female Mice, Medicine +10